Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
79,829,985
-
Shares change
-
-5,175,149
-
Total reported value, excl. options
-
$2,441,610,603
-
Value change
-
-$156,636,791
-
Put/Call ratio
-
174%
-
Number of buys
-
121
-
Number of sells
-
-84
-
Price
-
$30.58
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2024
233 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2024.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79,829,985 shares
of 80,437,135 outstanding shares and own 99.2% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,973,771 shares), WELLINGTON MANAGEMENT GROUP LLP (8,208,606 shares), BlackRock Inc. (7,772,140 shares), RTW INVESTMENTS, LP (7,393,127 shares), ARMISTICE CAPITAL, LLC (6,962,227 shares), COWEN AND COMPANY, LLC (3,756,469 shares), Camber Capital Management LP (3,500,000 shares), JANUS HENDERSON GROUP PLC (2,981,559 shares), STATE STREET CORP (2,749,340 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,787,780 shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.